CN Patent

CN103038356A — 乙酰半胱氨酸组合物及其使用方法

Assigned to Cumberland Pharmaceuticals Inc · Expires 2013-04-10 · 13y expired

What this patent protects

本发明公开用于向需要治疗的人类患者提供副作用减少的药物组合物和方法，其包括给药包含乙酰半胱氨酸的药物组合物。

USPTO Abstract

本发明公开用于向需要治疗的人类患者提供副作用减少的药物组合物和方法，其包括给药包含乙酰半胱氨酸的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103038356A
Jurisdiction
CN
Classification
—
Expires
2013-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Cumberland Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.